Cost-Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse Events

MLA

Michael N Dalili, et al. “Cost-Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse Events.” Value in Health, vol. 24, June 2021, pp. 780–88. EBSCOhost, https://doi.org/10.1016/j.jval.2020.12.012.

APA

Michael N Dalili, José A López-López, Deborah M Caldwell, Kyla H Thomas, Mark Stevenson, David Phillippo, Edna Keeney, Nicky J Welton, & Marcus R. Munafò. (2021). Cost-Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse Events. Value in Health, 24, 780–788. https://doi.org/10.1016/j.jval.2020.12.012

Chicago

Michael N Dalili, José A López-López, Deborah M Caldwell, Kyla H Thomas, Mark Stevenson, David Phillippo, Edna Keeney, Nicky J Welton, and Marcus R. Munafò. 2021. “Cost-Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse Events.” Value in Health 24 (June): 780–88. doi:10.1016/j.jval.2020.12.012.